None
Quote | Enlivex Therapeutics Ltd. (NYSE:ENLV)
Last: | $ |
---|---|
Change Percent: | 6.59% |
Open: | $8.35 |
Close: | $8.74 |
High: | $8.74 |
Low: | $8.231 |
Volume: | 5,431 |
Last Trade Date Time: | 02/12/2020 04:40:51 pm |
News | Enlivex Therapeutics Ltd. (NYSE:ENLV)
Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Comp...
2024-04-15 12:47:11 ET More on Mid-day movers & stocks. Enlivex stock plunges 50% on mixed results from sepsis study WiSA Technologies to effect 1-for-150 reverse stock split Seeking Alpha’s Quant Rating on BioSig Technologies, Inc. Historical earn...
Message Board Posts | Enlivex Therapeutics Ltd. (NYSE:ENLV)
Subject | By | Source | When |
---|---|---|---|
Fundamentals on this one are amazing | WolfKlaw | investorshub | 04/24/2021 4:28:44 AM |
Yeah, I call that "all steak and no | Clemdane | investorshub | 04/23/2021 7:05:39 PM |
This company has so much potential upside I | WolfKlaw | investorshub | 04/09/2021 9:20:41 AM |
You as well! | Clemdane | investorshub | 04/06/2021 3:59:52 PM |
Best of luck to you | WolfKlaw | investorshub | 04/05/2021 12:21:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Comp...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to...